Paula Marincola Smith, MD, PhD

Peer-Reviewed Articles

1. Tomita K, Marincola Smith P, Takayama M, Pan C, Shen S, Wang X, Wang XS, Williams LA, Arvide M, To C, Rajaram R, Rice D, Hofstetter W, Antonoff M, Mehran R, Vaporciyan A, Walsh G, Maxwell JE, Snyder RA, Kim MP, Tzeng CD, Mansfield P, Swisher S, Lee JE, Badgwell BD, G Katz MH, Ikoma N. Defining Postoperative Symptom Recovery in Patients Undergoing Upper Gastrointestinal Surgery: A Prospective Study Using the UGI Surgery Module of the MD Anderson Symptom Inventory. Ann Surg Oncol. e-Pub 2025.
2. Marincola Smith P, Lie J, Mansfield P, Song Y, White MG, Fournier KF, Helmink BA. Outcomes Following Palliative Cytoreduction with or without HIPEC in Patients with Unresectable Carcinomatosis of Appendiceal or Colorectal Primary. e-Pub 2025.
3. Marincola Smith P, Tomita K, Hirata Y, Cass S, Pan C, Shen S-E, Wang X, Wang XS, Williams L, Arvide M, To C, Rajaram R, Rice D, Hofstetter W, Antonoff M, Mehran R, Vaporciyan A, Walsh G, Maxwell J, Snyder R, Kim M, Tzeng C-W, Badgwell B, Mansfield P, Katz M, Lee J, Swisher S, Ikoma N. Psychometric Validation of a new MD Anderson Symptom Inventory (MDASI) Survey for Patients with Upper Gastrointestinal Cancers: MDASI-UGI-Surg. Ann Surg Onc. e-Pub 2025.
4. Marincola Smith P, Seldomridge A, Chiang Y, White MG, Song Y, Scally C, Mansfield PF, Fournier KF, Helmink BA. Outcomes Following Diagnostic Laparoscopy in Patients with Peritoneal Carcinomatosis Deemed Ineligible for Cytoreduction and Hyperthermic Chemotherapy (HIPEC) due to Disease Burden. Surg Oncol Insight 2(2):100150, 2025. e-Pub 2025.
5. Marincola Smith P, Martinez A, Irlmeier R, Solorzano C, Magge D, Ye F, Goldenring J. Factors Impacting Academic Productivity and Satisfaction of Surgeon-scientists. Ann Surg 281(3):445-453, 2025. e-Pub 2025.
6. Mirza MB, Baechle JJ, Marincola Smith P, Ali D, Dillhoff M, Poultsides G, Rocha FG, Cho CS, Winslow ER, Fields RC, Maithel SK, Idrees K. Insulin-dependence and Survival in Pancreatic Neuroendocrine Tumors: Results from the US-NETS Group. J Surg Oncol. e-Pub 2025.
7. White MG, Marincola Smith P, Bhutiani N, Helmink BA, Galbraith NJ, Kopetz E, Overman MJ, Mansfield PF, Fournier KF, Uppal A. Long-term outcomes of cytoreduction with or without heated intraperitoneal chemotherapy (HIPEC) for colorectal peritoneal metastases. J Am Coll Surg, 2025. e-Pub 2025.
8. Gelbard A, Shilts MH, Strickland B, Motz K, Tsai H-W, Boone H, Brake WP, Wanjalla C, Marincola Smith P, Brown H, Ramierez M, Atkinson JB, Powell J, Simpson J, Rajagopala SV, Mallal S, Sheng Q, Hillel AT, Das SR. Idiopathic subglottic stenosis arises at the interface of host and pathogen. J Am Coll Surg, 2025. e-Pub 2025.
9. Adams A, Marincola Smith P, Maxwell J. Validation of Specific Growth Rate as a Prognostic Indicator in Pancreatic Neuroendocrine Tumors. e-Pub 2025.
10. Marincola Smith P, Lie JJ, Seldomridge A, Galbraith NJ, Ramamurthy J, Song Y, Helmink BA, Mansfield PF, Fournier KF, White MG. Characterization of outcomes following repeat cytoreduction for metastatic colorectal cancer to the peritoneal cavity. Ann Surg Oncol. e-Pub 2025.
11. Cottam MA, Mirza MB, Arner E, Siddiqui MT, Marincola Smith P, Lipscombe C, Revetta F, Hatem Z, Tasneem N, Cameron A, Beckermann KE, Edwards J, Rathmell JC, Lau K, Washington K, Jamieson N, Raoof M, Idrees K. Regulatory macrophages contribute to tumor cell plasticity in colorectal metastases. Nature Communications. e-Pub 2025.
12. Marincola Smith P, Chen J, Seldomridge A, Hierl A, Fallon E, Kawedia JD, Qiao W, Liu X, Song Y, Mansfield PF, Fournier KF, White MG, Helmink B. Absorption of Cisplatin and Mitomycin C by healthcare workers participating in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) operations. e-Pub 2025.
13. Mirza MB, Choi J, Marincola Smith P, Padmanabhan C, Holowatyj AN, Shah SC, Guo X, Idrees K. ERBB2 amplification in gastric cancer: a genomic insight into ethnic disparities. J Natl Cancer Inst 116(11):1830-1833, 2024. e-Pub 2024.
14. Mirza MB, Baechle JJ, Marincola Smith P, Dillhoff M, Poultsides G, Rocha FG, Cho CS, Winslow ER, Fields RC, Maithel SK, Idrees K. Survival disparities in rural versus urban patients with pancreatic neuroendocrine tumor: A multi-institutional study from the US neuroendocrine tumor study group. Am J Surg, 2024. e-Pub 2024.
15. Mirza MB, Marincola Smith P, Wang Y, Naveed A, Washington MK, Xu Y, Idrees K. Intra-patient heterogeneity in micro-satellite-stable Colorectal Metastases: Does Immunotherapy Have a Role in Colorectal Peritoneal Metastases?. Ann Surg Oncol 31(3):1440-1443, 2024. e-Pub 2024.
16. Marincola Smith P, Tan MC. Gastrointestinal Bleeding in the Setting of Juvenile Polyposis Syndrome Due to SMAD4 Mutation. Am Surg 89(7):3328-3330, 2023. e-Pub 2023.
17. Rangel EL, Castillo-Angeles M, Marincola Smith P, Terhune K. Parental Support Policies and Benefits: A Surgical Training Program Report Card of Transparency. Ann Surg 277(6):938-943, 2023. e-Pub 2023.
18. Makris EA, Cannon JGD, Norton JA, Lopez-Aguiar AG, Dillhoff M, Beal E, Idrees K, Marincola Smith P, Rocha FG, Kanji Z, Cho C, Beems M, Weber S, Fisher A, Krasnick BA, Fields RC, Maithel SK, Poultsides GA. Calcifications and Cystic Morphology on Preoperative Imaging Predict Survival After Resection of Pancreatic Neuroendocrine Tumors. Ann Surg Oncol 30(4):2424-2430, 2023. e-Pub 2023.
19. Hanna DN, Marincola Smith P, Novitskiy SV, Washington MK, Zi J, Weaver CJ, Hamaamen JA, Lewis KB, Zhu J, Yang J, Liu Q, Beauchamp RD, Means AL. SMAD4 Suppresses Colitis-associated Carcinoma Through Inhibition of CCL20/CCR6-mediated Inflammation. Gastroenterology 163(5):1334-1350e14, 2022. e-Pub 2022.
20. Baechle JJ, Marincola Smith P, Ortega CA, Wang TS, Solorzano CC, Kiernan CM. Clinical Predictors of Pseudohypoxia-Type Pheochromocytomas. Ann Surg Oncol 29(6):3536-3546, 2022. e-Pub 2022.
21. Zhang X, Xue F, Dong D, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Marincola Smith P, Cho C, Beems M, Lv Y, Maithel SK, Pawlik TM. New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors: A Multi-institutional and National Data Analysis. Ann Surg 274(1):e28-e35, 2021. e-Pub 2021.
22. Marincola Smith P, Choksi YA, Markham NO, Hanna DN, Zi J, Weaver CJ, Hamaamen JA, Lewis KB, Yang J, Liu Q, Kaji I, Means A, Beauchamp RD. Colon epithelial cell TGFβ signaling modulates the expression of tight junction proteins and barrier function in mice. Am J Physiol Gastrointest Liver Physiol 320(6):G936-G957, 2021. e-Pub 2021.
23. Apple R, Marincola Smith P, Craft P, Roumie C, Terhune KP. Assessing Utilization, Benefits, and Shortfalls of Lactation Resources for Physician Trainees and Other Healthcare Providers. Clin Lact (Amarillo) 12(2), 2021. e-Pub 2021.
24. Heidsma CM, Tsilimigras DI, van Dieren S, Rocha F, Abbott DE, Fields R, Marincola Smith P, Poultsides GA, Cho C, Dillhoff M, Lopez-Aguiar AG, Kanji Z, Fisher A, Krasnick BA, Idrees K, Makris E, Beems M, van Eijck CHJ, can Dijkum EJMN, Maithel S, Pawlik TM. Indications and outcomes of enucleation versus formal pancreatectomy for pancreatic neuroendocrine tumors. HPB 23(3):413-421, 2021. e-Pub 2021.
25. Baechle JJ, Marincola Smith P, Solorzano CC, Tran TB, Postlewait LM, Maithel SK, Prescott J, Pawlik T, Wang TS, Glenn J, Hatzaras I, Shenoy R, Phay JE, Shirley LA, Fields RC, Jin L, Abbott DE, Ronnekliev-Kelly S, Sicklick JK, Yopp A, Mansour J, Duh Q-Y, Seiser N, Votanopoulos K, Levine E, Poultsides G, Kiernan CM. Cumulative GRAS Score as a Predictor of Survival After Resection for Adrenocortical Carcinoma: Analysis From the U.S. Adrenocortical Carcinoma Database. Ann Surg Oncol 28:6551-6561, 2021. e-Pub 2021.
26. Sahara K, Tsilimigras DI, Moro A, Mehta R, Dillhoff M, Heidsma CM, Lopez-Aguiar AG, Maithel SK, Rocha FG, Kanji Z, Abbott DE, Fisher A, Fields RC, Krasnick BA, Idrees K, Marincola Smith P, Poultsides GA, Makris E, Cho CS, Beems M, Endo I, Pawlik TM. Long-Term Outcomes after Spleen-Preserving Distal Pancreatectomy for Pancreatic Neuroendocrine Tumors: Results from the US Neuroendocrine Study Group. Neuroendocrinology 111(1-2):129-138, 2021. e-Pub 2021.
27. Heidsma CM, Tsilimigras DI, Rocha F, Abbott DE, Fields RC, Marincola Smith P, Poultsides GA, Cho C, ven Eijck C, van Dijkum EN, Maithel SK, Pawlik TM. Clinical relevance of performing endoscopic ultrasound-guided fine-needle biopsy for pancreatic neuroendocrine tumors less than 2 cm. J Surg Oncol 122(7):1393-1400, 2020. e-Pub 2020.
28. Baechle JJ, Lopez AM, Thota J, Bowers MF, Marincola Smith P, Offodile RS. Enhancement of medical student perception of surgical specialization with peer-assisted laparoscopic simulation: a pilot study. Journal of Surgical Simulation 7:73-79, 2020. e-Pub 2020.
29. Dong D-H, Zhang X-F, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Marincola Smith P, Cho C, Beems M, Schmidt CR, Dillhoff M, Maithel SK, Pawlik TM. Tumor burden score predicts tumor recurrence of non-functional pancreatic neuroendocrine tumors after curative resection. HPB 22(8):1149-1157, 2020. e-Pub 2020.
30. Xu-Feng Z, Feng X, Zheng W, Lopez-Aguiar AG, Poultsides G, Eleftherios M, Rocha F, Zaheer K, Weber S, Fisher A, Fields R, Idrees K, Marincola Smith P, Cho C, Beems M, Lyu Y, Maithel SK, Pawlik TM. Development and Validation of a Modified Eighth AJCC Staging System for Primary Pancreatic Neuroendocrine Tumors. Ann Surg 275(6):e773-e780, 2020. e-Pub 2020.
31. Barrett JR, Rendell V, Pokrzywa C, Lopez-Aguiar AG, Cannon J, Poultsides GA, Rocha F, Crown A, Beal E, Pawlik TM, Fields R, Panni RZ, Marincola Smith P, Idrees K, Cho C, Beems M, Maithel S, Weber S, Abbott DE. Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors provides no recurrence or survival benefit. J Surg Oncol 121(7):1067-1073, 2020. e-Pub 2020.
32. Baechle JJ, Marincola Smith P, Tan M, Solorzano CC, Lopez-Aguiar AG, Dillhoff M, Beal EW, Poultsides G, Makris E, Rocha FG, Crown A, Cho C, Beems M, Winslow ER, Rendell VR, Krasnick BA, Fields R, Maithel SK, Bailey CE, Idrees K. Specific Growth Rate as a Predictor of Survival in Pancreatic Neuroendocrine Tumors: A Multi-institutional Study from the United States Neuroendocrine Study Group. Ann Surg Oncol 27(10):3915-3923, 2020. e-Pub 2020.
33. Sahara K, Tsilimigras DI, Mehta R, Moro A, Paredes AZ, Lopez-Aguiar AG, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Marincola Smith P, Poultsides G, Makris E, Cho C, Beems M, Dillhoff M, Maithel SK, Endo I, Pawlik TM. Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis. Ann Surg Oncol 27(4):1203-1212, 2020. e-Pub 2020.
34. Marincola Smith P, Baechle JJ, Tan MC, Solorzano CC, Lopez-Aguiar AG, Dillhoff M, Beal EW, Poultsides G, Cannon JGD, Rocha FG, Crown A, Cho CS, Beems M, Winslow ER, Rendell VR, Krasnick BA, Fields RC, Maithel SK, Bailey CE, Idrees K. Impact of Insurance Status on Survival in Gastroenteropancreatic Neuroendocrine Tumors. Ann Surg Oncol 27(9):3147-3153, 2020. e-Pub 2020.
35. Heidsma CM, Hyer M, Tsilimigras DI, Rocha F, Abbott DE, Fields R, Marincola Smith P, Poultsides GA, Cho C, Maithel SK, Pawlik TM. Incidence and impact of Textbook Outcome among patients undergoing resection of pancreatic neuroendocrine tumors: Results of the US Neuroendocrine Tumor Study Group. J Surg Oncol 121(8):1201-1208, 2020. e-Pub 2020.
36. Prendergast KM, Marincola Smith P, Tran TB, Postlewait LM, Maithel SK, Prescott JD, Pawlik TM, Wang TS, Glenn J, Hatzaras I, Shenoy R, Phay JE, Shirley LA, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh Q, Seiser N, Votanopoulos KI, Levine EA, Poultsides GA, Solórzano CC, Kiernan CM. Features of synchronous versus metachronous metastasectomy in adrenal cortical carcinoma: Analysis from the US adrenocortical carcinoma database. Surgery 167(2):352-357, 2020. e-Pub 2020.
37. Dong D, Zhang X, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Marincola Smith P, Cho C, Beems M, Dillhoff M, Maithel SK, Pawlik TM. Resection of pancreatic neuroendocrine tumors: defining patterns and time course of recurrence. HPB 22(2):215-223, 2020. e-Pub 2020.
38. Trudeau M, Maggino L, Ecker B, Vollmer C, PHRARYGB Study Group. Pancreatic Head Resection Following Roux-en-Y Gastric Bypass: Operative Considerations and Outcomes. J Gastrointest Surg 24(1):76-87, 2020. e-Pub 2020.
39. Marincola Smith P, Baechle J, Solorzano CC, Tan M, Lopez-Aguiar AG, Dillhoff M, Beal E, Poultsides G, Cannon JGD, Rocha FG, Crown A, Cho C, Beems M, Winslow ER, Rendell VR, Krasnick BA, Fields RC, Maithel SK, Bailey CE, Idrees K. Impact of Perioperative Blood Transfusion on Survival in Pancreatic Neuroendocrine Tumor Patients: Analysis from the US Neuroendocrine Study Group. HPB. HPB 22(7):1042-1050, 2020. e-Pub 2020.
40. Wu L, Sahara K, Tsilimigras DI, Maithel SK, Poultsides GA, Rocha FG, Weber SM, Fields RC, Idrees K, Cho CS, Shen F, Pawlik TM, USNET Study Group. Therapeutic index of lymphadenectomy among patients with pancreatic neuroendocrine tumors: A multi-institutional analysis. J Surg Oncol 120(7):1080-1086, 2019. e-Pub 2019.
41. Dong D, Zhang X, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Pawlik TM, USNET Study Group. Impact of tumor size and nodal status on recurrence of nonfunctional pancreatic neuroendocrine tumors ≤2 cm after curative resection: A multi-institutional study of 392 cases. J Surg Oncol 120(7):1071-1079, 2019. e-Pub 2019.
42. Armstrong EA, Beal EW, Lopez-Aguiar AG, Poultsides G, Cannon JG, Rocha F, Crown A, Barrett J, Ronnkleiv-Kelly S, Fields RC, Krasnick BA, Idrees K, Marincola Smith P, Nathan H, Beems MV, Maithel SK, Schmidt CR, Pawlik TM, Dillhoff M. Evaluating the ACS-NSQIP Risk Calculator in Primary GI Neuroendocrine Tumor: Results from the United States Neuroendocrine Tumor Study Group. Am Surg, 2019. e-Pub 2019. PMID: 31908214.
43. Crown A, Simianu VV, Kennecke H, Lopez-Aguiar AG, Dillhoff M, Beal EW, Poultsides GA, Makris E, Idrees K, Marincola Smith P, Nathan H, Beems M, Abbott D, Barrett J, Fields RC, Davidson J, Maithel S, Rocha F. Appendiceal Neuroendocrine Tumors: Does Colon Resection Improve Outcomes?. J Gastrointest Surg 24(9):2121-2126, 2019. e-Pub 2019.
44. Dave A, Beal EW, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha FG, Kanji Z, Ronnekleiv-Kelly S, Rendell VR, Fields RC, Krasnick BA, Idrees K, Marincola Smith P, Nathan H, Beems M, Maithel SK, Pawlik TM, Schmidt CR, Dillhoff ME. Evaluating the ACS NSQIP Risk Calculator in Primary Pancreatic Neuroendocrine Tumor: Results from the US Neuroendocrine Tumor Study Group. J Gastrointest Surg 23(11):2225-2231, 2019. e-Pub 2019.
45. Xu-Feng Zhang MD, PhD, Xiao-Ning Wu MD, Diamantis I Tsilimigras MD, George Poultsides MD, Flavio Rocha MD, Daniel E Abbott MD, Ryan Fields MD, Kamran Idrees MD, Cliff Cho MD, Shishir K Maithel MD, Timothy M Pawlik MD, MPH, PhD, USNET Study Group. Duodenal neuroendocrine tumors: Impact of tumor size and total number of lymph nodes examined. J Surg Oncol 120:1302-1310, 2019. e-Pub 2019.
46. DePalo DK, Lee RM, Lopez-Aguiar AG, Gamboa AC, Rocha F, Poultsides G, Dillhoff M, Fields RC, Idrees K, Nathan H, Abbott D, Maithel SK, Russell MC, USNET Study Group. Interaction of race and pathology for neuroendocrine tumors: Epidemiology, natural history, or racial disparity?. J Surg Oncol 120(6):919-925, 2019. e-Pub 2019.
47. Zhang X, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fields R, Krasnick BA, Idrees K, Marincola Smith P, Cho C, Schmidt CR, Maithel SK, Pawlik TM, Study Group USNT. Minimally invasive versus open distal pancreatectomy for pancreatic neuroendocrine tumors: An analysis from the U.S. neuroendocrine tumor study group. J Surg Oncol 120(2):231-240, 2019. e-Pub 2019.
48. Lopez-Aguiar AG, Zaidi MY, Beal EW, Dillhoff M, D Cannon JG, Poultsides GA, Kanji ZS, Rocha FG, Marincola Smith P, Idrees K, Beems M, Cho CS, Fisher AV, Weber SM, Krasnick BA, Fields RC, Cardona K, Maithel SK. Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group. Ann Surg Oncol 26(8):2517-2524, 2019. e-Pub 2019.
49. Crown A, Kennecke H, Kozarek R, Lopez-Aguiar AG, Dillhoff M, Beal EW, Poultsides GA, Makris E, Idrees K, Marincola Smith P, Nathan H, Beems M, Abbott D, Fisher AV, Fields RC, Davidson J, Maithel SK, Rocha FG. Gastric carcinoids: Does type of surgery or tumor affect survival?. Am J Surg 217(5):937-342, 2019. e-Pub 2019.
50. Fisher AV, Lopez-Aguiar AG, Rendell VR, Pokrzywa C, Rocha FG, Kanji ZS, Poultsides GA, Makris EA, Dillhoff ME, Beal EW, Fields RC, Panni RZ, Idrees K, Marincola Smith P, Cho CS, Beems MV, Maithel SK, Winslow ER, Abbott DE, Weber SM. Predictive Value of Chromogranin A and a Pre-Operative Risk Score to Predict Recurrence After Resection of Pancreatic Neuroendocrine Tumors. J Gastrointest Surg 23(4):651-658, 2019. e-Pub 2019.
51. Kimbrough CW, Beal EW, Dillhoff ME, Schmidt CR, Pawlik TM, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha FG, Crown A, Abbott DE, Fisher AV, Fields RC, Krasnick BA, Idrees K, Marincola Smith P, Cho CS, Beems M, Maithel SK, Cloyd JM. Influence of carcinoid syndrome on the clinical characteristics and outcomes of patients with gastroenteropancreatic neuroendocrine tumors undergoing operative resection. Surgery 165(3):657-663, 2019. e-Pub 2019.
52. Zaidi MY, Lopez-Aguiar AG, Poultsides GA, Dillhoff M, Rocha FG, Idrees K, Nathan H, Winslow ER, Fields RC, Cardona K, Maithel SK, USNET Study Group. The impact of failure to achieve symptom control after resection of functional neuroendocrine tumors: An 8-institution study from the US Neuroendocrine Tumor Study Group. J Surg Oncol 119(1):5-11, 2018. e-Pub 2018.
53. Zaidi MY, Lopez-Aguiar AG, Dillhoff M, Beal E, Poultsides G, Makris E, Rocha F, Crown A, Idrees K, Marincola Smith P, Nathan H, Beems M, Abbott D, Barrett JR, Fields RC, Davidson J, Cardona K, Maithel SK. Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small-Bowel Neuroendocrine Tumors. JAMA Surg 154(2):134-140, 2018. e-Pub 2018.
54. Chakedis J, Beal EW, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha FG, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Marincola Smith P, Cho C, Beems M, Pawlik TM, Maithel SK, Schmidt CR, Dillhoff M. Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms. J Gastrointest Surg 23(1):122-134, 2018. e-Pub 2018.
55. Zhang XF, Wu Z, Cloyd J, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Marincola Smith P, Cho C, Beems M, Schmidt CR, Dillhoff M, Maithel SK, Pawlik TM. Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group. Surgery 165(3):548-556, 2018. e-Pub 2018.
56. Marincola Smith P, Kiernan CM, Tran TB, Postlewait LM, Maithel SK, Prescott J, Pawlik T, Wang TS, Glenn J, Hatzaras I, Shenoy R, Phay J, Shirley LA, Fields RC, Jin L, Weber S, Salem A, Sicklick J, Gad S, Yopp A, Mansour J, Duh Q, Seiser N, Votanopoulos K, Levine EA, Poultsides G, Solórzano CC. Role of Additional Organ Resection in Adrenocortical Carcinoma: Analysis of 167 Patients from the U.S. Adrenocortical Carcinoma Database. Ann Surg Oncol 25(8):2308-2315, 2018. e-Pub 2018.
57. Kiernan CM, Marincola Smith P, Feng Z, Solorzano CC. Robotic Resection of an 8 mm Nonexophitic Pancreatic Insulinoma. VideoEndocrinology 5(3), 2018. e-Pub 2018.
58. Means AL, Freeman TJ, Zhu J, Woodbury LG, Marincola Smith P, Wu C, Meyer AR, Weaver CJ, Padmanabhan C, An H, Zi J, Wessinger BC, Chaturvedi R, Brown TD, Deane NG, Coffey RJ, Wilson KT, Smith J, Sawyers CL, Goldenring JR, Novitskiy SV, Washington M, Shi C, Beauchamp R. Epithelial Smad4 Deletion Up-Regulates Inflammation and Promotes Inflammation-Associated Cancer. Cell Mol Gastroenterol Hepatol 6(3):257-276, 2018. e-Pub 2018.
59. Merath K, Bagante F, Beal EW, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Marincola Smith P, Cho C, Beems M, Schmidt CR, Dillhoff M, Maithel SK, Pawlik TM. Nomogram predicting the risk of recurrence after curative-intent resection of primary non-metastatic gastrointestinal neuroendocrine tumors: An analysis of the U.S. Neuroendocrine Tumor Study Group. J Surg Oncol 117(5):868-878, 2018. e-Pub 2018.
60. Marincola P, Gonzalez RS, Shi C, Poulose B, Parikh A. Cholangiocarcinoma arising from intraductal papillary mucinous neoplasm of the bile duct. Am Surg 81(3):E102-3, 2015. e-Pub 2015. PMID: 25760180.
61. Robinson JR, Marincola P, Shelton J, Merchant NB, Idrees K, Parikh AA. Peri-operative risk factors for delayed gastric emptying after a pancreaticoduodenectomy. HPB 17(6):495-501, 2015. e-Pub 2015.
62. Whitney G, Daves S, Hughes A, Watkins S, Woods M, Kreger M, Marincola P, Chocron I, Donahue B. Implementation of a transfusion algorithm to reduce blood product utilization in pediatric cardiac surgery. Paediatr Anaesth 23(7):639-46, 2013. e-Pub 2013.
63. Cizza G, Marincola P, Mattingly M, Williams L, Mitler M, Skarulis M, Csako G. Treatment of obesity with extension of sleep duration: a randomized, prospective, controlled trial. Clin Trials 7(3):274-85, 2010. e-Pub 2010.

Invited Articles

1. Baechle JJ, Marincola Smith P, Kiernan CM. ASO Author Reflections: Cumulative GRAS Score Predicts Outcomes After Resection for Adrenal Cortical Carcinoma. Ann Surg Oncol 28(11):6562-6563, 2021. e-Pub 2021.
2. Baechle JJ, Marincola Smith P, Idrees K. ASO Author Reflections: Elevated Preoperative Specific Growth Rate is Associated with Shortened Survival After Resection for Pancreatic Neuroendocrine Tumors. Ann Surg Oncol 27:3924-3925, 2020. e-Pub 2020.
3. Marincola Smith P, Baechle JJ, Idrees K. ASO Author Reflections: Uninsurance is Associated with Worse Outcomes Following Resection for Gastro-Entero-Pancreatic Neuroendocrine Tumors. Ann Surg Oncol 27:3154-3155, 2020. e-Pub 2020.
4. Marincola Smith P, Kiernan CM, Solórzano CC. ASO Author Reflections: Additional Organ Resection in Adrenocortical Carcinoma. Ann Surg Oncol 25(Suppl 3):872-873, 2018. e-Pub 2018.

Review Articles

1. Coukos G, Donia M, Gastman B, Goff S, Gros A, Harari A, Hernandez S, Ito F, Maker A, Marincola Smith P, Mullinax J, Murthy P, Pai S, Prabhakaran S, Restifo N, Silver N, Turcotte S, Wagner P, Yang J, Lotze MT. The Science of Tumor Infiltrating Lymphocytes (TIL): Perspectives from the SITC Surgery Committee. JITC. e-Pub 2025.
2. Marincola Smith P, Means AL, Beauchamp RD. Immunomodulatory Effects of TGF-β Family Signaling within Intestinal Epithelial Cells and Carcinomas. Gastrointest Disord (Basel) 1(2):290-300, 2019. e-Pub 2019.
3. Liu E, Marincola P, Öberg K. Everolimus in the treatment of patients with advanced pancreatic neuroendocrine tumors: latest findings and interpretations. Therap Adv Gastroenterol 6(5):412-419, 2013. e-Pub 2013.

Other Articles

1. Baechle JJ, Marincola Smith P, Idrees K Insurance-based Disparities in Gastro-Entero-Pancreatic Neuroendocrine Tumor Patients. J Health Care Poor Underserved 32(3):1199-1207, 2021.

Editorials

1. Marincola Smith P, Nordness MF, Polcz ME. The American Board of Surgery Should Reconsider Its Parental Leave Policy. JAMA Surg 157(1):7-8, 2021.

Abstracts

1. Marincola Smith P. Psychometric Validation of a new MD Anderson Symptom Inventory Survey for Patients with Upper Gastrointestinal Cancers: MDASI-UGI-Surg. Society for Surgical Oncology.
2. Marincola P. Decreasing Packed Red Blood Cell utilization with Computerized Provider Order Entry and Decision Support in a Tertiary Care Children’s Hospital. Vanderbilt School of Medicine Student Research Forum.
3. Marincola P. Utilizing the Case-Manager Format in the Student-Run Clinic Setting. Society for Student Run Free Clinics.
4. Marincola P. Perioperative Risk factors for Delayed Gastric Emptying After Pancreaticoduodenectomy. American College of Surgeons.
5. Marincola P. Cholangiocarcinoma arising from an intraductal papillary mucinous neoplasm of the bile duct (IPMN-B). Southeastern Surgical Congress.
6. Marincola Smith P. Surgical resident wellness and opportunities for improvement: A single center pilot survey. Academic Surgical Congress.
7. Marincola Smith P. Effect of Transfusion on Survival for Resected Pancreatic Neuroendocrine Tumors: Analysis of the U.S. Neuroendocrine Study group. AHPBA.
8. Marincola Smith P. Role of Additional Organ Resection in Adrenocortical Carcinoma: Analysis of 167 patients from the US Adrenocortical Carcinoma Database. Society for Surgical Oncology.
9. Marincola Smith P. Impact of insurance status on survival in neuroendocrine tumors: A multi-institutional Study from the U.S. Neuroendocrine Study Group. Gastrointestinal Cancer Symposium (GI-ASCO).
10. Marincola Smith P. SMAD4 signaling within colon epithelium suppresses inflammation and inflammation-associated cancer. Vanderbilt Ingram Cancer Center Annual Scientific Retreat.
11. Marincola Smith P. TGFbeta signaling within colonic epithelial cells modulates inflammation and intestinal barrier function in mice. Academic Surgical Congress.
12. Marincola Smith P. The Ccl20/Ccr6 Axis Promotes Colitis-Associated Carcinogenesis in Smad4 Conditional Knockout Mice. Society for Surgical Oncology.
13. Marincola Smith P. Canonical TGFβ signaling regulates critical junctional protein expression in mice. Academic Surgical Congress.
14. Marincola Smith P. Genomic and Immunophenotypic Alterations in Colorectal Cancer Peritoneal Metastases Compared to Matched Hematogenous Metastases. Society for Surgical Oncology.
15. Marincola Smith P. Outcomes following “failed” diagnostic laparoscopy in patients with peritoneal carcinomatosis not amendable to cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC). Advanced Cancer Therapies.

Book Chapters

1. Marincola Smith P, R Davis. Pancreatic Cyst-Gastrostomy. In: Open Manual of Surgery in Resource-Limited Settings, 2023.
2. Marincola Smith P, Terhune KP. Meaning/Purpose in Work. In: Wellbeing. Springer International Publishing, 2020.
3. Rose B, Idrees K, Marincola Smith P, Russell M. Critical Element 2: Extent of Resection in Gallbladder Cancer. In: American College of Surgeons Cancer Research Program Operative Standards for Cancer Surgery (OSCS) – Volume III. Wolters Kluwer Health Publishing, 2020.
4. Marincola P, Liu E. The History of Neuroendocrine Tumors. In: Neuroendocrine Tumors: Diagnosis and Management, 2015.
5. Marincola Smith P, Guriab Trueba M, Behman R, Huey R, Helmink B, Morris V, Alonso Martinez S, You N. Colorectal Cancer. In: Abeloff's Clinical Oncology, Seventh Edition. Elsevier.